Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD

Nephrology Dialysis Transplantation

Volumn 27, Issue 7, 2012, Pages 2847-2853

  Ennis, Jennifer ^a   Worcester, Elaine ^b   Coe, Fredric ^b  

^a LithoLink Corporation   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

African American; chronic kidney disease; mineral metabolism; parathyroid hormone

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RACE DIFFERENCE; SECONDARY HYPERPARATHYROIDISM; UNITED STATES; VITAMIN BLOOD LEVEL;

AFRICAN AMERICANS; AGED; CALCIUM; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; PHOSPHORUS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D;

EID: 84864398761     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs080     Document Type: Article

References (27)

1. Bricker NS, Slatopolsky E, Reiss E et al. Calcium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med 1969; 123: 543-553.
2. Slatopolsky E, Delmez JA. Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 1994; 23: 229-236.
3. Kates DM, Sherrard DJ, Andress DL. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 1997; 30: 809-813.
4. Lopez-Hilker S, Dusso AS, Rapp NS et al. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990; 259: F432-F437.
5. LaClair RE, Hellman RN, Karp SL et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005; 45: 1026-1033.
6. Gonzalez EA, Sachdeva A, Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510.
7. Menon S, Valentini RP, Hidalgo G et al. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 2008; 23: 1831-1836.
8. Kandula P, Dobre M, Schold JD et al. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011; 6: 50-62.
9. Pitts TO, Piraino BH, Mitro R et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 1988; 67: 876-881.
10. Larsson T, Nisbeth U, Ljunggren O et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003; 64: 2272-2279.
11. Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215.
12. Evenepoel P, Meijers B, Viaene L et al. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 2010; 5: 1268-1276.
13. De Boer IH, Gorodetskaya I, Young B et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 2002; 13: 2762-2769.
14. Vassalotti JA, Uribarri J, Chen SC et al. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S56-S68.
15. Inaba M, Nagasue K, Okuno S et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 2002; 39: 1261-1269.
16. Inaba M, Okuno S, Nagasue K et al. Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients. Am J Kidney Dis 2001; 38: S139-S142.
17. Gutiérrez OM, Isakova T, Andress DL et al. Prevalence and severity of disordered mineral metabolism in blacks with chronic kidney disease. Kidney Int 2008; 73: 956-962.
18. Bell NH, Greene A, Epstein S et al. Evidence for alteration of the vitamin d-endocrine system in blacks. J Clin Invest 1985; 76: 470-473.
19. Gutiérrez OM, Farwell WR, Kermah D et al. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2011; 22: 1745-1753.
20. Gutiérrez OM, Isakova T, Smith K et al. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrol Dial Transplant 2010; 25: 3970-3977.
21. Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378.
22. Gutiérrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592.
23. Sawaya BP, Butros R, Naqvi S et al. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int 2003; 64: 737-742.
24. Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium-analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 2011; 26: 1368-1376.
25. Gupta A, Kallenbach LR, Zasuwa G et al. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000; 11: 330-334.
26. Moore C, Yee J, Malluche H et al. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1484-1493.
27. Paik JM, Curhan GC, Forman JP et al. Determinants of plasma parathyroid hormone levels in young women. Calcif Tissue Int 2010; 87: 211-217.